Crinetics Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small-molecule therapeutics for rare endocrine diseas... Crinetics Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small-molecule therapeutics for rare endocrine diseases and endocrine-related tumors. Its proprietary platform targets key hormone receptor signaling pathways, including somatostatin, ACTH, and others, to create orally bioavailable drugs that address dysregulated hormone activity and improve patient convenience. The lead product, PALSONIFY (paltusotine), is an approved once-daily oral somatostatin receptor type 2 agonist for treating acromegaly, with ongoing evaluation for carcinoid syndrome in neuroendocrine tumors. The company is advancing atumelnant, an oral ACTH receptor antagonist for congenital adrenal hyperplasia and Cushing’s disease, and CRN09682, a nonpeptide drug conjugate from its proprietary platform for SST2-positive solid tumors. Crinetics Pharmaceuticals Inc. supports these efforts with an integrated approach combining medicinal chemistry, translational biology, and clinical development, positioning it as a key player in addressing unmet needs in endocrinology and GPCR-targeted oncology. Founded in 2008 and headquartered in San Diego, California, the company operates a commercial infrastructure to deliver therapies to patients with rare hormonal disorders.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

No Greenhouse Gas (GHG) Emissions data disclosed by Crinetics Pharmaceuticals

We reviewed Crinetics Pharmaceuticals's website and available disclosure materials for the 2023 reporting period and did not identify any reported Greenhouse Gas (GHG) Emissions data.

If you would like us to review newly published materials or reassess the most recent disclosures, you can submit a data update request.

Would you like us to review Crinetics Pharmaceuticals's data?

Start your 30-day free trial to request a data review for Crinetics Pharmaceuticals.

Start Free Trial

Legal Center Contact Us

Crinetics Pharmaceuticals Inc

No Greenhouse Gas (GHG) Emissions data disclosed by Crinetics Pharmaceuticals

Account Restricted